Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular pathways in glioblastoma-derived stem cells to identify effective drug agents: A bioinformatics study. | J Family Med Prim Care | 2022 | 36119333 | PubTator, text mining | PubMed |
| Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. | J Hematol Oncol | 2022 | 36104717 | PubTator, text mining | PubMed |
| Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers. | Chin Med J (Engl) | 2022 | 36103972 | PubTator, text mining | PubMed |
| Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases. | Genet Res (Camb) | 2022 | 36101743 | PubTator, text mining | PubMed |
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans. | Front Immunol | 2022 | 36090990 | PubTator, text mining | PubMed |
| A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast. | Breast Cancer Res Treat | 2022 | 36085534 | PubTator, text mining | PubMed |
| Editorial: Outcome prediction in pituitary adenomas. | Front Endocrinol (Lausanne) | 2022 | 36082071 | PubTator, text mining | PubMed |
| DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36077818 | PubTator, text mining | PubMed |
| Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma. | Cancers (Basel) | 2022 | 36077749 | PubTator, text mining | PubMed |
| Risk Stratification for Breast Cancer Patient by Simultaneous Learning of Molecular Subtype and Survival Outcome Using Genetic Algorithm-Based Gene Set Selection. | Cancers (Basel) | 2022 | 36077657 | PubTator, text mining | PubMed |
| Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer. | PLoS One | 2022 | 36067173 | PubTator, text mining | PubMed |
| Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs. | Front Cell Dev Biol | 2022 | 36060800 | PubTator, text mining | PubMed |
| PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer. | Front Mol Biosci | 2022 | 36060253 | PubTator, text mining | PubMed |
| The roles of glycolysis in osteosarcoma. | Front Pharmacol | 2022 | 36059961 | PubTator, text mining | PubMed |
| LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p. | Front Oncol | 2022 | 36059662 | PubTator, text mining | PubMed |
| Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma. | J Clin Endocrinol Metab | 2022 | 36059148 | PubTator, text mining | PubMed |
| Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas. | Front Oncol | 2022 | 36052250 | PubTator, text mining | PubMed |
| Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer. | Oxid Med Cell Longev | 2022 | 36035209 | PubTator, text mining | PubMed |
| Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma. | J Oncol | 2022 | 36016582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=24